NeuroCOVID: it's time to join forces globally
Authors:
- Raimund HelbokRHRaimund Helbok
- Sherry Hsiang-Yi ChouSCSherry Hsiang-Yi Chou
- Ettore BeghiEBEttore Beghi
- Shraddha MainaliSMShraddha Mainali
- Jennifer FronteraJFJennifer Frontera
- Courtney RobertsonCRCourtney Robertson
- Ericka FinkEFEricka Fink
- Michelle SchoberMSMichelle Schober
- Elena MoroEMElena Moro
- Molly McNettMMMolly McNett
- Claudio L BassettiCBClaudio L Bassetti
- 1 October 2020
- journal article
- letter
- Published by Elsevier in The Lancet Neurology
- Vol. 19 (10) , 805-806
Abstract
No abstract availableFunding Information
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Center for Advancing Translational Sciences (R21NS113037, UL1 TR001857)
- University of Pittsburgh
- Center for Clinical and Translational Science, University of Illinois at Chicago (UL1TR002733)
- National Institutes of Health
- Ministero della Salute
This publication has 5 references indexed in Scilit:
- The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infectionEuropean Journal of Neurology, 2020
- Neurologic Features in Severe SARS-CoV-2 InfectionNew England Journal of Medicine, 2020
- The neurological impact of COVID-19The Lancet Neurology, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and RationaleNeurocritical Care, 2020